|
Volumn 70, Issue 13, 2017, Pages 1680-1681
|
Application of the Statin-Associated Muscle Symptoms-Clinical Index to a Randomized Trial on Statin Myopathy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PLACEBO;
SIMVASTATIN;
DIFFERENTIAL DIAGNOSIS;
DISEASE MARKER;
HUMAN;
LETTER;
MYOPATHY;
PATIENT CODING;
POST HOC ANALYSIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RECEIVER OPERATING CHARACTERISTIC;
SCORING SYSTEM;
STATIN ASSOCIATED MUSCLE SYMPTOMS CLINICAL INDEX;
STATISTICAL ANALYSIS;
SYMPTOM;
CHEMICALLY INDUCED;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
MUSCLE DISEASE;
RANDOMIZED CONTROLLED TRIAL;
SENSITIVITY AND SPECIFICITY;
SEVERITY OF ILLNESS INDEX;
SKELETAL MUSCLE;
CROSS-OVER STUDIES;
DOUBLE-BLIND METHOD;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MUSCLE, SKELETAL;
MUSCULAR DISEASES;
SENSITIVITY AND SPECIFICITY;
SEVERITY OF ILLNESS INDEX;
|
EID: 85028501756
PISSN: 07351097
EISSN: 15583597
Source Type: Journal
DOI: 10.1016/j.jacc.2017.07.767 Document Type: Letter |
Times cited : (26)
|
References (5)
|